Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1149281 | 0.81 | TSHR (0.45) | TSHRMEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL17354923 | 0.81 | TSHR (0.45) | TSHRMEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL19025403 | 0.76 | ANPEP (0.44) | TSHRALDH1A1CYP1A2POLBCYP3A4 | |
| SCHEMBL6338975 | 0.74 | LMNA (0.40) | TSHRALDH1A1CYP3A4HTR2A | |
| SCHEMBL10393559 | 0.73 | LMNA (0.47) | PKMTSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL475203 | 0.73 | CPA1 (0.47) | TSHRANPEPERAP1ERAP2 | |
| SCHEMBL7268763 | 0.73 | TDP1 (0.52) | TSHRALDH1A1CYP3A4HTR2AANPEP | |
| SCHEMBL30146557 | 0.73 | TDP1 (0.52) | TSHRALDH1A1CYP3A4HTR2AANPEP | |
| SCHEMBL30146580 | 0.73 | TDP1 (0.52) | TSHRALDH1A1CYP3A4HTR2AANPEP | |
| SCHEMBL102138 | 0.73 | TRPA1 (0.56) | TRPA1TSHRMEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969775-B2 | Method of producing organic compounds in presence of oxyethylene ether catalyst and in a solvent minimized environment | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2005-11-29 | — | — | US | disclosed |
| US-20040138509-A1 | Method of producing organic compounds in presence of oxyethylene ether catalyst and in a solvent minimized environment | THE TEXAS A&M UNIVERSITY SYSTEM | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138509-A1 | Method of producing organic compounds in presence of oxyethylene ether catalyst and in a solvent minimized environment | CYP2E1, CYP3A43, CYP1A2 | PKM 1966/4885TRPA1 222/4885TSHR 3174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.